companydata.dkcompanydata.dk

BIONORDIKA DENMARK A/S: Financial statements 2024

CVR: 17150774

Source: annual report 2024, Danish Business Authority

01/01/2024 – 31/12/2024

BIONORDIKA DENMARK A/S (CVR 17150774) has filed annual accounts for 2024. In 2024, the company reported a gross profit of DKK 16,231,945 and a net result of DKK 6,279,422 compared with DKK 6,256,860 the year before. That is an increase of 16.9% compared with the year before. Equity in the 2024 report amounted to DKK 25,603,894. The solvency ratio was 82%. The company had 11 employees in the financial year.

Gross Profit
DKK 16,231,945
Profit/Loss
DKK 6,279,422
Equity
DKK 25,603,894
Total Assets
DKK 31,221,057
Employees
11

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2024-16.2M6.3M25.6M11
2023-13.9M6.3M29.3M11
2022-54.8M36.4M59.1M11
2021-92.5M65M87.7M11
2020-43.4M28M29.7M10

Official annual report

View the official annual report directly on the page with a Pro subscription.

Screen every Danish company

Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.

Try company screening

Events in 2024

BIONORDIKA DENMARK A/S: The 2023 annual report is outApr 15, 2024

BIONORDIKA DENMARK A/S has published its annual report for 2023. Gross profit came to DKK 13,881,740, and the net result was DKK 6,256,860.

Michael Hartmann joins the board of BIONORDIKA DENMARK A/SApr 5, 2024

As of April 5, 2024, Michael Hartmann has joined the board of directors of BIONORDIKA DENMARK A/S.

Peter Simonsbacka leaves the board of BIONORDIKA DENMARK A/SApr 5, 2024

As of April 5, 2024, Peter Simonsbacka has left the board of directors of BIONORDIKA DENMARK A/S.

About BIONORDIKA DENMARK A/S

BIONORDIKA DENMARK A/S is a Danish company of the type Aktieselskab based in Herlev, founded in 1993. The company is registered under the industry Engroshandel med andre maskiner og andet udstyr. The company was previously named MEDINOVA SCIENTIFIC A/S and ApS KBUS 38 NR. 2890. The management consists of Kirsten Skovmøller Lysemose. The board consists of Jussi Sakari Kurittu (chair), Haakon Rivertz Torgersen, Kirsten Skovmøller Lysemose and Michael Hartmann. The company is owned by BioNordika Holding AB. The company has 12 employees (2026). In 2025, the company reported a gross profit of DKK 14,623,391 and a net result of DKK 4,736,523 compared with DKK 6,279,422 the year before. Equity in the 2025 report amounted to DKK 23,840,415.

Source: annual report 2025, Danish Business Authority